These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

791 related items for PubMed ID: 34908453

  • 1. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
    Mahey N, Tambat R, Chandal N, Verma DK, Thakur KG, Nandanwar H.
    Microbiol Spectr; 2021 Dec 22; 9(3):e0095121. PubMed ID: 34908453
    [Abstract] [Full Text] [Related]

  • 2. Antifungal Azoles as Tetracycline Resistance Modifiers in Staphylococcus aureus.
    Mahey N, Tambat R, Verma DK, Chandal N, Thakur KG, Nandanwar H.
    Appl Environ Microbiol; 2021 Jul 13; 87(15):e0015521. PubMed ID: 33990311
    [Abstract] [Full Text] [Related]

  • 3. 1,3,4-oxadiazole conjugates of capsaicin as potent NorA efflux pump inhibitors of Staphylococcus aureus.
    Naaz F, Khan A, Kumari A, Ali I, Ahmad F, Ahmad Lone B, Ahmad N, Ali Khan I, Rajput VS, Grover A, Shafi S.
    Bioorg Chem; 2021 Aug 13; 113():105031. PubMed ID: 34089943
    [Abstract] [Full Text] [Related]

  • 4. Efflux pump inhibitory potential of indole derivatives as an arsenal against norA over-expressing Staphylococcus aureus.
    Chandal N, Tambat R, Kalia R, Kumar G, Mahey N, Jachak S, Nandanwar H.
    Microbiol Spectr; 2023 Sep 27; 11(5):e0487622. PubMed ID: 37754560
    [Abstract] [Full Text] [Related]

  • 5. Clinically Approved Drugs Inhibit the Staphylococcus aureus Multidrug NorA Efflux Pump and Reduce Biofilm Formation.
    Zimmermann S, Klinger-Strobel M, Bohnert JA, Wendler S, Rödel J, Pletz MW, Löffler B, Tuchscherr L.
    Front Microbiol; 2019 Sep 27; 10():2762. PubMed ID: 31849901
    [Abstract] [Full Text] [Related]

  • 6. Unlocking bacterial defense: Exploring the potent inhibition of NorA efflux pump by coumarin derivatives in Staphylococcus aureus.
    Martin ALAR, Pereira RLS, Rocha JE, Farias PAM, Freitas TS, Caldas FRL, Figueredo FG, Sampaio NFL, Oliveira-Tintino CDM, Tintino SR, da Hora GCA, Lima MCP, de Menezes IRA, Carvalho DT, Coutinho HDM, Fonteles MMF.
    Microb Pathog; 2024 May 27; 190():106608. PubMed ID: 38503396
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial activity of Mimosa caesalpiniifolia Benth and its interaction with antibiotics against Staphylococcus aureus strains overexpressing efflux pump genes.
    Silva SWC, Monção NBN, Araújo BQ, Arcanjo DDR, Ferreira JHL, Lima Neto JS, Citó AMGL, de Siqueira Júnior JP, Kaatz GW, Barreto HM.
    Lett Appl Microbiol; 2019 Jul 27; 69(1):57-63. PubMed ID: 31002429
    [Abstract] [Full Text] [Related]

  • 8. New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains.
    Felicetti T, Cedraro N, Astolfi A, Cernicchi G, Mangiaterra G, Vaiasicca S, Massari S, Manfroni G, Barreca ML, Tabarrini O, Biavasco F, Cecchetti V, Vignaroli C, Sabatini S.
    Eur J Med Chem; 2022 Nov 05; 241():114656. PubMed ID: 35963131
    [Abstract] [Full Text] [Related]

  • 9. Dithiazole thione derivative as competitive NorA efflux pump inhibitor to curtail multi drug resistant clinical isolate of MRSA in a zebrafish infection model.
    Lowrence RC, Raman T, Makala HV, Ulaganathan V, Subramaniapillai SG, Kuppuswamy AA, Mani A, Chittoor Neelakantan S, Nagarajan S.
    Appl Microbiol Biotechnol; 2016 Nov 05; 100(21):9265-9281. PubMed ID: 27531512
    [Abstract] [Full Text] [Related]

  • 10. Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives.
    Fontaine F, Héquet A, Voisin-Chiret AS, Bouillon A, Lesnard A, Cresteil T, Jolivalt C, Rault S.
    Eur J Med Chem; 2015 May 05; 95():185-98. PubMed ID: 25817769
    [Abstract] [Full Text] [Related]

  • 11. Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus.
    Rath SK, Singh S, Kumar S, Wani NA, Rai R, Koul S, Khan IA, Sangwan PL.
    Bioorg Med Chem; 2019 Jan 15; 27(2):343-353. PubMed ID: 30552006
    [Abstract] [Full Text] [Related]

  • 12. Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors.
    Astolfi A, Felicetti T, Iraci N, Manfroni G, Massari S, Pietrella D, Tabarrini O, Kaatz GW, Barreca ML, Sabatini S, Cecchetti V.
    J Med Chem; 2017 Feb 23; 60(4):1598-1604. PubMed ID: 28117588
    [Abstract] [Full Text] [Related]

  • 13. Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors.
    Cannalire R, Mangiaterra G, Felicetti T, Astolfi A, Cedraro N, Massari S, Manfroni G, Tabarrini O, Vaiasicca S, Barreca ML, Cecchetti V, Biavasco F, Sabatini S.
    Int J Mol Sci; 2020 Sep 24; 21(19):. PubMed ID: 32987835
    [Abstract] [Full Text] [Related]

  • 14. Deciphering the Molecular Recognition Mechanism of Multidrug Resistance Staphylococcus aureus NorA Efflux Pump Using a Supervised Molecular Dynamics Approach.
    Palazzotti D, Bissaro M, Bolcato G, Astolfi A, Felicetti T, Sabatini S, Sturlese M, Cecchetti V, Barreca ML, Moro S.
    Int J Mol Sci; 2019 Aug 19; 20(16):. PubMed ID: 31430864
    [Abstract] [Full Text] [Related]

  • 15. Discovery of novel dihydronaphthalene-imidazole ligands as potential inhibitors of Staphylococcus aureus multidrug resistant NorA efflux pump: A combination of experimental and in silico molecular docking studies.
    A Malik A, Dangroo NA, Kaur P, Attery S, A Rather M, Khan A, Ara T, Nandanwar H.
    Microb Pathog; 2024 May 19; 190():106627. PubMed ID: 38521473
    [Abstract] [Full Text] [Related]

  • 16. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
    Sabatini S, Kaatz GW, Rossolini GM, Brandini D, Fravolini A.
    J Med Chem; 2008 Jul 24; 51(14):4321-30. PubMed ID: 18578473
    [Abstract] [Full Text] [Related]

  • 17. Effect of palladium(II) complexes on NorA efflux pump inhibition and resensitization of fluoroquinolone-resistant Staphylococcus aureus: in vitro and in silico approach.
    Shobana R, Thahirunnisa JH, Sivaprakash S, Amali AJ, Solomon AP, Suresh D.
    Front Cell Infect Microbiol; 2023 Jul 24; 13():1340135. PubMed ID: 38292858
    [Abstract] [Full Text] [Related]

  • 18. Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus.
    Kalia NP, Mahajan P, Mehra R, Nargotra A, Sharma JP, Koul S, Khan IA.
    J Antimicrob Chemother; 2012 Oct 24; 67(10):2401-8. PubMed ID: 22807321
    [Abstract] [Full Text] [Related]

  • 19. Aminoguanidine hydrazones (AGH's) as modulators of norfloxacin resistance in Staphylococcus aureus that overexpress NorA efflux pump.
    Dantas N, de Aquino TM, de Araújo-Júnior JX, da Silva-Júnior E, Gomes EA, Gomes AAS, Siqueira-Júnior JP, Mendonça Junior FJB.
    Chem Biol Interact; 2018 Jan 25; 280():8-14. PubMed ID: 29208359
    [Abstract] [Full Text] [Related]

  • 20. Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump.
    Sabatini S, Gosetto F, Manfroni G, Tabarrini O, Kaatz GW, Patel D, Cecchetti V.
    J Med Chem; 2011 Aug 25; 54(16):5722-36. PubMed ID: 21751791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.